Tilray Brands (TLRY) Assets Average (2018 - 2026)
Tilray Brands (TLRY) posted Assets Average of $2.1 billion for Q1 2026, little changed on a QoQ basis from $2.1 billion in Q4 2025.
Tilray Brands (TLRY) Assets Average (2018 - 2026) Analysis & Trends
Tilray Brands' Assets Average history runs 9 years deep, the most recent figure standing at $2.1 billion for Q1 2026.
- Quarterly Assets Average changed N/A year-over-year to $2.1 billion in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $2.1 billion (changed N/A YoY) and the FY2025 annual result came in at $3.1 billion, down 26.18% from the prior year.
- Assets Average was $2.1 billion for Q1 2026 at Tilray Brands, roughly flat from $2.1 billion in the prior quarter.
- Across five years, Assets Average topped out at $5.8 billion in Q1 2022 and bottomed at $2.1 billion in Q3 2025.
- A 5-year average of $4.2 billion and a median of $4.3 billion in 2023 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2024 — Assets Average retreated 2.59% — and 2025, when it sank 51.0%.
- Tilray Brands' Assets Average stood at $5.5 billion in 2022, then retreated by 21.09% to $4.4 billion in 2023, then decreased by 3.2% to $4.2 billion in 2024, then sank by 50.54% to $2.1 billion in 2025, then dropped by 0.19% to $2.1 billion in 2026.
- Business Quant data shows TLRY's Assets Average at $2.1 billion in Q1 2026, $2.1 billion in Q4 2025, and $2.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | 2.09 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 2.09 Bn |
| Nov 30, 2025 | 2.09 Bn |
| Aug 31, 2025 | 2.08 Bn |
| Nov 30, 2024 | 4.23 Bn |
| Aug 31, 2024 | 4.24 Bn |
| May 31, 2024 | 4.22 Bn |
| Feb 29, 2024 | 4.27 Bn |
| Nov 30, 2023 | 4.37 Bn |
| Aug 31, 2023 | 4.35 Bn |
| May 31, 2023 | 4.34 Bn |
| Feb 28, 2023 | 4.93 Bn |
| Nov 30, 2022 | 5.53 Bn |
| Aug 31, 2022 | 5.52 Bn |
| May 31, 2022 | 5.63 Bn |
| Feb 28, 2022 | 5.79 Bn |
| Nov 30, 2021 | 5.87 Bn |
| Aug 31, 2021 | 6.01 Bn |
| May 31, 2020 | 1.33 Bn |
| Mar 31, 2020 | 905.95 Mn |
| Dec 31, 2019 | 968.27 Mn |